Axa
DVAX

Axa’s Dynavax Technologies DVAX Stock Holding History

Axa’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-187,800
Closed -$2.63M – 1080
2023
Q4 		$2.63M Buy
187,800
+6,000
+3% +$83.3K 0.01% 681
2023
Q3 		$2.69M Hold
181,800
– – 0.01% 663
2023
Q2 		$2.35M Sell
181,800
-3,500
-2% -$39.9K 0.01% 693
2023
Q1 		$1.82M Buy
185,300
+67,900
+58% +$725K 0.01% 784
2022
Q4 		$1.25M Buy
117,400
+87,800
+297% +$1.02M ﹤0.01% 848
2022
Q3 		$309K Buy
29,600
+1,600
+6% +$20.8K ﹤0.01% 1033
2022
Q2 		$353K Buy
+28,000
New +$297K ﹤0.01% 1017
2021
Q4 		– Sell
-20,300
Closed -$390K – 1201
2021
Q3 		$390K Buy
+20,300
New +$270K ﹤0.01% 1100
2020
Q3 		– Sell
-15,600
Closed -$138K – 1301
2020
Q2 		$138K Buy
+15,600
New +$78.8K ﹤0.01% 1195
2019
Q3 		– Sell
-300,500
Closed -$1.2M – 1313
2019
Q2 		$1.2M Buy
+300,500
New +$1.74M ﹤0.01% 941
2017
Q3 		– Sell
-230,900
Closed -$2.23M – 1322
2017
Q2 		$2.23M Buy
230,900
+19,700
+9% +$128K 0.01% 762
2017
Q1 		$1.26M Hold
211,200
– – 0.01% 877
2016
Q4 		$834K Sell
211,200
-65,012
-24% -$476K ﹤0.01% 942
2016
Q3 		$2.9M Buy
276,212
+92
+0% +$1.32K 0.01% 677
2016
Q2 		$4.03M Sell
276,120
-11,307
-4% -$193K 0.02% 602
2016
Q1 		$5.53M Buy
287,427
+76,076
+36% +$1.54M 0.02% 539
2015
Q4 		$5.11M Sell
211,351
-4,443
-2% -$111K 0.02% 556
2015
Q3 		$5.3M Buy
+215,794
New +$6.11M 0.02% 551

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa's DVAX Position: Q1 2024 in Review

Axa sold out of Dynavax Technologies (DVAX) in Q1 2024, closing a stake of 187,800 shares — an estimated $2.63M sold.

Axa first reported a position in DVAX in Q3 2015 and held it in 18 quarters. The position peaked at $5.53M in Q1 2016. 244 funds tracked by Wall St. Rank hold DVAX as of Q1 2024.

  • Axa reported no remaining Dynavax Technologies position as of Q1 2024 after selling out during the quarter.
  • Axa sold 187,800 Dynavax Technologies shares in Q1 2024, an estimated $2.63M.
  • Axa first reported a position in Dynavax Technologies in Q3 2015 and held it in 18 quarters.
  • Axa's Dynavax Technologies position peaked at $5.53M in Q1 2016.
  • 244 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.